Literature DB >> 14619451

Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.

Esther A Torres1, Ramón De Jesús, Cynthia M Pérez, Michael Iñesta, Daniel Torres, Carlos Morell, Erica Just.   

Abstract

OBJECTIVES: Limited data exists about Inflammatory Bowel Disease (IBD) in Hispanic populations. The aims of the present study were to estimate overall and specific prevalence of IBD (Crohn's disease and ulcerative colitis) and to describe the characteristics of a group of patients from the University of Puerto Rico's IBD Registry.
METHODS: To estimate the prevalence of IBD, computerized records of all physician billing and hospital discharges from a major health insurer in Puerto Rico and classified with ICD-9-CM codes 555.0-555.9 (Crohn's disease) and 556.0-556.9 (ulcerative colitis) during 1996 were searched. Prevalence was estimated by age group, sex, and type of insurance. To describe demographic and selected clinical information from patients with IBD, data gathered in the University of Puerto Rico's IBD Registry from 1995 through 2000 was analyzed.
RESULTS: Out of 802,726 insured individuals, 332 had a diagnosis of Crohn's disease, 499 of ulcerative colitis and 21 had both diagnoses. The estimated prevalence per 100,000 was 41.4 for Crohn's disease, 62.2 for ulcerative colitis, and 106.1 cases per 100,000 for IBD. Peak prevalence of Crohn's disease occurred among the age groups 50-59 years and > or = 60 years, and the overall female:male prevalence ratio of Crohn's disease was 1.13 (95% CI: 0.91-1.42). Ulcerative colitis was most prevalent among insured individuals aged 50-59 years and 40-49 years. The prevalence of ulcerative colitis was significantly higher among females than among males, with an overall prevalence ratio of 1.42 (95% CI: 1.18-1.71). Of 342 patients participating in the IBD Registry, 155 (45.3%) had Crohn's disease and 187 (54.7%) had ulcerative colitis. Among patients diagnosed with Crohn's disease, 51.6% were females, the mean age was 35.2 +/- 18.3 years, and 18.1% had a family history of IBD. More than half (57.8%) of patients with ulcerative colitis were females, the mean age was 42.6 +/- 17 years, and 17.1% had a family history of IBD.
CONCLUSIONS: The estimated prevalence of IBD in this insured population in Puerto Rico places it among the middle-range of that reported for other countries. Additional studies must be conducted in Puerto Rico in order to confirm the observed findings. Population-based epidemiologic studies aimed at estimating the burden of IBD in Hispanic populations in the United States and Latin America are essential for health care planning.

Entities:  

Mesh:

Year:  2003        PMID: 14619451

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN: 0738-0658            Impact factor:   0.705


  10 in total

1.  Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization.

Authors:  Dan Li; Bernadette Collins; Fernando S Velayos; Liyan Liu; James D Lewis; James E Allison; Nicole T Flowers; Susan Hutfless; Oren Abramson; Lisa J Herrinton
Journal:  Dig Dis Sci       Date:  2013-10-31       Impact factor: 3.199

2.  Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease.

Authors:  Yamilka Abreu-Delgado; Raymond A Isidro; Esther A Torres; Alexandra González; Myrella L Cruz; Angel A Isidro; Carmen I González-Keelan; Priscilla Medero; Caroline B Appleyard
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Rates of inflammatory bowel disease in Hispanics comparable to non-Hispanic Whites: results of a cohort study.

Authors:  Alex Zhornitskiy; Stacy Shen; Long B Le; Brian M Fung; Felicia Zhornitsky; Tom Liang; Berkeley N Limketkai; Jenny S Sauk; James H Tabibian
Journal:  Int J Colorectal Dis       Date:  2021-01-07       Impact factor: 2.571

4.  Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland.

Authors:  Alicja Wiercinska-Drapalo; Jerzy Jaroszewicz; Robert Flisiak; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

5.  Inflammatory bowel disease characteristics and treatment in Hispanics and Caucasians.

Authors:  Jason Hou; Hashem El-Serag; Joseph Sellin; Selvi Thirumurthi
Journal:  Dig Dis Sci       Date:  2011-03-11       Impact factor: 3.199

6.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

7.  Epidemiology of inflammatory bowel disease among an indigent multi-ethnic population in the United States.

Authors:  Hoda M Malaty; Jason K Hou; Selvi Thirumurthi
Journal:  Clin Exp Gastroenterol       Date:  2010-12-06

8.  Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry.

Authors:  Esther A Torres; Abdiel Cruz; Mariola Monagas; Marina Bernal; Yadira Correa; Rafael Cordero; Víctor L Carlo
Journal:  Int J Inflam       Date:  2011-12-11

Review 9.  Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies.

Authors:  Jesús K Yamamoto-Furusho
Journal:  Pharmgenomics Pers Med       Date:  2017-05-26

10.  Comparison of Simple Eudragit Microparticles Loaded with Prednisolone and Eudragit-Coated Chitosan-Succinyl-Prednisolone Conjugate Microparticles: Part II. In Vivo Evaluation of Efficacy, Toxicity, and Biodisposition Characteristics.

Authors:  Hiraku Onishi; Hisashi Kikuchi
Journal:  Int J Mol Sci       Date:  2015-11-02       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.